Has Malcolm Beaudett, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,170 in general payments to Malcolm Beaudett, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Malcolm Beaudett, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Malcolm Beaudett, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Malcolm Beaudett, MD

Psychiatry · Portsmouth, NHNPI 1184682544

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$3,170in general payments, 2019–2025

Across 76 payments — averaging $41.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$564
Alkermes, Inc.$506
AbbVie$447
Lundbeck LLC$408
Axsome Therapeutics, Inc.$375
Ironshore Pharmaceuticals Inc.$142
plus $728 from 9 others

What the payments were for

Food & beverage$3,14099%
Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	11	$564
Alkermes, Inc.	7	$506
AbbVie(2 entities)	10	$447
Lundbeck LLC	18	$408
Axsome Therapeutics, Inc.	10	$375
Ironshore Pharmaceuticals Inc.	7	$142
E.r. Squibb & Sons, L.L.C.	2	$135
Otsuka America Pharmaceutical, Inc.	1	$125
Sunovion Pharmaceuticals Inc.	1	$124
Biogen	1	$107
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$98
Eisai Inc.	4	$85
Collegium Pharmaceutical, Inc.	1	$23
Teva Pharmaceuticals USA, Inc.	1	$17
Corium, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,170 in reported general payments places this provider in the 85th percentile of 166 psychiatry providers in New Hampshire.

See all psychiatry providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$59,241

Medicare patients

Services billed

768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lisdexamfetamine Dimesylate	30	$9,467
BelsomraSuvorexant	14	$9,167
TrintellixVortioxetine Hydrobromide	11	$4,950
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	34	$2,711
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	14	$1,688
Gabapentin	31	$1,526
Aripiprazole	29	$1,167
Clonazepam	84	$1,070
Duloxetine Hcl	27	$982
Escitalopram Oxalate	31	$863
Trazodone Hcl	15	$785
Lorazepam	82	$767
Hydroxyzine Hcl	12	$595
Quetiapine Fumarate	17	$524
Bupropion Hcl SrBupropion Hcl	24	$502

Paid to pharmacies, not to this prescriber.

Other psychiatry in Portsmouth

Wassfy HannaPortsmouth$10K
George NowakPortsmouth$3K
Joshua ColePortsmouth$3K
Andrew MorrisPortsmouth$2K
David SchopickPortsmouth$2K
Richard TombPortsmouth$1K
Rekha RaoPortsmouth$758
John MillerExeter$2.7M
Stephen EllenNashua$1.4M
Michael McNamaraManchester$754K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →